India Biotech inks agreement with Preciosa Medicants to deliver Covaxin to Brazil
Recently India Biotech has signed an agreement with Precisa Medicamentos for the supply of Kovid-19 vaccine ‘Covaxin’ made in India in Brazil. The supply of covaxin through direct procurement by the Brazilian government will be preferred for the public market.
A team from Precisea Medicaments visited India Biotech’s Facilitation Center in Gnome Valley last week to discuss the export of COVAXIN, India’s first indigenous vaccine made for Covid-19.
Leave a Reply